Skip to content

Clinical trials

Completed Hyperlipidemias trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Status: Completed Country / region: United States Clear all

244 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20024
20034
200417
200518
200614
200714
20087
200910
201014
201118
201212
201313
20148
201515
201612
20177
20186
20197
20206
20218
20226
20234
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed244

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer17
Amgen14
AstraZeneca7
Esperion Therapeutics, Inc.7
Takeda7
VA Office of Research and Development6
Emory University5
University of Colorado, Denver5
HealthPartners Institute4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias244
Hypertension65
Diabetes Mellitus51
Hypercholesterolemia44
Dyslipidemias43
Cardiovascular Diseases42
Obesity29
HIV Infections17
Atherosclerosis15
Coronary Artery Disease15

Trials

Showing 1 to 25 of 244. Each trial links to its page on Pharma Observatory.

144 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.